Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
A full-time postdoctoral fellow position is available in Professor Wenyi Wang's lab at the Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center
-
that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals. Responsibilities The candidate will lead
-
technical expertise but must also contain a well-defined training element and a qualification plan must be established for the scholarship period. Biostatistical competence and experience in working with
-
research associate in a post-doctoral position to study CD8 T-cell targeting of human tumor cells via immunopeptidome shift technologies in conjunction with novel T cell receptor (TCR) mechanobiology
-
clear data presentation, ability to work efficiently in a team and with collaborators Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage Previous
-
, the individual may have the opportunity to engage in clinical care, integrating informatics tools and strategies directly into patient interactions. Qualifications: Education: Successful applicants must hold an MD
-
populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated
-
educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals. Responsibilities Design and implement studies to evaluate
-
and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical
-
/graduate applying for their first postdoctoral fellowship in epigenetics in leukemia. Led by Dr. Emily Heikamp, MD PhD, our work focuses on high-risk forms of pediatric leukemia that are driven by oncogenic